BG Medicine Files for IPO on Euronext Amsterdam Exchange | GenomeWeb
NEW YORK (GenomeWeb News) - BG Medicine today said it has filed for an initial public offering of its shares on the Euronext Amsterdam Exchange.
 
The biomarker and diagnostics developer said it has filed a registration statement with the US Securities and Exchange Commission but has not yet determined the number of shares it plans to issue and it has not set an opening price for its common stock.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.